Amplify Weight Loss Drug & Treatment ETF Rating $23.17 +0.30 (+1.31%) (As of 11/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.75Holdings in THNR have an aggregate rating of Moderate Buy based on 192 analyst ratings issued in the past year covering 16 companies (69.0% of the portfolio).THNR Aggregate Price Target$23.17High Prediction$23.17Average Prediction$23.17Low Prediction$23.17Holdings in THNR have an aggregate price target of $23.17 and a range of $23.17 to $23.17 covering 16 companies (69.0% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 16 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.69%LLYEli Lilly and Company$749.34-0.5%4.9913 of 5 stars2.81$1,007.94 34.5%21Analyst Revision13.17%NVONovo Nordisk A/S$103.01-2.1%4.2387 of 5 stars2.86$144.50 40.3%7Options Volume5.36%AMGNAmgen$290.14+0.8%4.9132 of 5 stars2.46$333.57 15.0%26Ex-DividendShort Interest ↓Positive News4.95%PFEPfizer$25.07+0.5%5 of 5 stars2.50$32.92 31.3%16Analyst DowngradeAnalyst RevisionNews Coverage4.90%TMOThermo Fisher Scientific$515.19+0.5%4.9906 of 5 stars2.86$649.33 26.0%22Buyback AnnouncementPositive News4.81%MRKMerck & Co., Inc.$99.38+2.0%4.9964 of 5 stars2.68$130.86 31.7%19Dividend IncreasePositive News4.51%AZNAstraZeneca$63.87+1.1%3.9932 of 5 stars2.92$89.75 40.5%12Analyst UpgradeAnalyst Revision4.41%WSTWest Pharmaceutical Services$316.59+1.6%4.9689 of 5 stars2.67$460.33 45.4%3Analyst Revision3.67%TEVATeva Pharmaceutical Industries$17.05+0.1%2.7027 of 5 stars2.78$19.67 15.3%92.63%VKTXViking Therapeutics$53.60+4.0%4.7807 of 5 stars3.09$109.80 104.9%11Analyst Forecast2.56%GPCRStructure Therapeutics$31.18-4.7%2.3011 of 5 stars3.00$86.80 178.4%6Analyst Revision1.97%CTLTCatalent$59.69+1.2%3.0517 of 5 stars2.00$63.40 6.2%70.85%HIMSHims & Hers Health$22.80+4.6%3.5811 of 5 stars2.38$20.71 -9.1%16Analyst ForecastInsider Trade0.21%OPKOPKO Health$1.57-0.9%4.472 of 5 stars3.00$2.75 75.7%30.21%ALTAltimmune$8.81+9.4%1.9389 of 5 stars2.88$20.00 127.0%8Analyst Revision0.14%TERNTerns Pharmaceuticals$5.67+1.3%4.3387 of 5 stars2.83$27.25 380.6%6 This page (NYSEARCA:THNR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THNR Stock Alerts